Thank you. I will read more about it. One might conjecture the starting material for “SEC” analysis might vary from tumor lysate, blood, lymph and their immune constituents, and that changes over time, for instance, after targeting many antigens and what remaining and new cancer adaptations appear will be known on a real time basis.
The interesting part is that all these BPs are recruiting people with skills on SEC.
This has got to be a joke.
BP's are hiring people with expertiese in tools of the trade. Really, who would have guessed?
Of course DS is trying to imply some more nonsense about BP looking into this because NWBO/LL used it. As totally absurd as when he was arguing Merck was building a vaccine facility for NWBO because Merck does not manufacture vaccines.
News 
Market Data 
Discover 
